Soil concentrations of Polychlorinated Biphenyl in a typical Nigerian University environment and its risk assessment

Autor: Olusola Adedayo Adesina, Ifesinachi Ezengwa, Khadijat Abdulkareem Abdulraheem, Adesanmi J. Adewole, Okedere B. Oyetunji

Publikováno v: Case Studies in Chemical and Environmental Engineering, Vol 7, Iss , Pp 100343- (2023)

In this study, concentration of Polychlorinated Biphenyl (PCBs) around a university environment was investigated. The study further assessed the risk assessment associated with human contact with the soil using health indexes such as Hazard Quotient

Externí odkaz: https://doaj.org/article/01f7dc5d43394715ada9b43674a3b95b

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.

Autor: Pitt JJ; Institute for Genomics and Systems Biology, University of Chicago, Chicago, IL, 60637, USA.; Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore 117599, Singapore., Riester M; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA., Zheng Y; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA., Yoshimatsu TF; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA., Sanni A; Department of Pathology and Forensic Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., Oluwasola O; Department of Pathology, University of Ibadan, Ibadan, Oyo, Nigeria., Veloso A; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA., Labrot E; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA., Wang S; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.; Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing 100191, China., Odetunde A; Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria., Ademola A; Department of Surgery, University of Ibadan, Ibadan, Oyo, Nigeria., Okedere B; Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria., Mahan S; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA., Leary R; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA., Macomber M; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA., Ajani M; Department of Pathology, University of Ibadan, Ibadan, Oyo, Nigeria., Johnson RS; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA., Fitzgerald D; Institute for Genomics and Systems Biology, University of Chicago, Chicago, IL, 60637, USA., Grundstad AJ; Institute for Genomics and Systems Biology, University of Chicago, Chicago, IL, 60637, USA., Tuteja JH; Institute for Genomics and Systems Biology, University of Chicago, Chicago, IL, 60637, USA., Khramtsova G; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA., Zhang J; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA., Sveen E; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA., Hwang B; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA., Clayton W; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA., Nkwodimmah C; Department of Surgery, University of Ibadan, Ibadan, Oyo, Nigeria., Famooto B; Department of Surgery, University of Ibadan, Ibadan, Oyo, Nigeria., Obasi E; Department of Pathology and Forensic Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., Aderoju V; Department of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., Oludara M; Department of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., Omodele F; Department of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., Akinyele O; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA., Adeoye A; Department of Pathology, University of Ibadan, Ibadan, Oyo, Nigeria., Ogundiran T; Department of Surgery, University of Ibadan, Ibadan, Oyo, Nigeria., Babalola C; Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.; Department of Pharmaceutical Chemistry, University of Ibadan, Ibadan, Oyo, Nigeria., MacIsaac K; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA., Popoola A; Oncology Unit, Department of Radiology, Lagos State University, Ikeja, Lagos, Nigeria., Morrissey MP; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA., Chen LS; Department of Public Health Sciences, University of Chicago, Chicago, IL, 60637, USA., Wang J; Department of Public Health Sciences, University of Chicago, Chicago, IL, 60637, USA., Olopade CO; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA., Falusi AG; Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria., Winckler W; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA., Haase K; The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK., Van Loo P; The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.; Department of Human Genetics, University of Leuven, Oude Markt 13, Leuven 3000, Belgium., Obafunwa J; Department of Pathology and Forensic Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., Papoutsakis D; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA., Ojengbede O; Centre for Population and Reproductive Health, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria., Weber B; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA., Ibrahim N; Department of Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., White KP; Institute for Genomics and Systems Biology, University of Chicago, Chicago, IL, 60637, USA. kpwhite@uchicago.edu.; Tempus Labs, Inc., Chicago, IL, USA. kpwhite@uchicago.edu., Huo D; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA. dhuo@health.bsd.uchicago.edu.; Department of Public Health Sciences, University of Chicago, Chicago, IL, 60637, USA. dhuo@health.bsd.uchicago.edu., Olopade OI; Institute for Genomics and Systems Biology, University of Chicago, Chicago, IL, 60637, USA. folopade@medicine.bsd.uchicago.edu.; Center for Clinical Cancer Genetics & Global Health, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA. folopade@medicine.bsd.uchicago.edu., Barretina J; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA. jordi.barretina@gmail.com.; Girona Biomedical Research Institute (IDIBGI), 17007, Girona 17007, Spain. jordi.barretina@gmail.com.

Publikováno v: Nature communications [Nat Commun] 2019 Jan 14; Vol. 10 (1), pp. 288. Date of Electronic Publication: 2019 Jan 14.